Gilead Sciences Inc.

Gilead Sciences Inc. Stock

17.98P/E
€188.27BMarket capitalisation
-US$3.13Earnings
1.88 %Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis Cdrug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).

Gilead Sciences Inc. is registered in the following country: United States of America (Exchange: USNASD).

Key metrics

Key metrics and master data for the Gilead Sciences Inc. stock.

Market capitalisation
€188.27B
P/E
17.98
P/B
16.00
P/S
6.63
P/CF
14.45
Issued shares 1B Units

Return

Here you can see the performance of the Gilead Sciences Inc. stock.

PeriodPerfor­mance
1 Week-0.52 %
1 Month+11.49 %
3 Months+21.36 %
6 Months+35.36 %
1 Year+40.11 %
YTD+44.22 %

Dividends

The Gilead Sciences Inc. stock pays an annual dividend. With an (expected) annual dividend of £2.9403, the current stock price results in a dividend yield of 1.88 %.

Dividend typeAnnual dividend
(Expected) annual dividend £2.9403
Dividend yield 1.88 %

Splits

The table shows the splits of the Gilead Sciences Inc. share.

DateRatio
28.01.20131:0.5
25.06.20071:0.5
07.09.20041:0.5
08.03.20022:1
22.02.20012:1

Which ETF contains the Gilead Sciences Inc. stock?

The Gilead Sciences Inc. stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, Gilead Sciences Inc. has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the Gilead Sciences Inc. stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.